HealthStream (HSTM) Misses Q4 EPS by 5c

Go back to HealthStream (HSTM) Misses Q4 EPS by 5c

Needham & Company Reiterates Buy on HealthStream (HSTM) Following 4Q

February 23, 2017 7:03 AM EST

Needham & Company reiterated a Buy rating and $28.00 price target on HealthStream (NASDAQ: HSTM) following the company's 4Q earnings report. 4Q revenues and EPS of $58.7mm/$0.02 came in below $61.4mm/$0.04 estimates.

Analyst Scott Berg commented, "HSTM reported 4Q revenue/EPS results below our... More

Cantor Fitzgerald Reiterates Neutral Rating and $27 PT on HealthStream (HSTM) Following 'Light' 4Q16 Results

February 22, 2017 6:52 AM EST

Cantor Fitzgerald analyst Steven Halper reiterates Neutral rating and $27 price target on HealthStream Inc. (NASDAQ: HSTM), as the company offered solid 2017 revenue guidance, offsetting 2016 fourth quarter results that were below consensus estimates.

Halper comments, "After the close on Tuesday, February 21, HealthStream reported 4Q16... More